International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Brain metastases are a common complication in patients with cancer and are an increasingly important cause of morbidity and mortality (1). They develop in 10–30% of adults and in 6–10% of children with cancer (2–8). In adults, the most common types of primary tumor responsible for brain metastases are lung (50%), breast (15–20%), unknown primary (10–15%), melanoma (10%), and colon (5%) (2,3). In children, the most common source of brain metastases are sarcomas, neuroblastoma, and germ cell tumors (2,9). Metastases from breast, colon, and renal cell carcinoma are frequently single, while melanoma and lung cancer have a greater tendency to produce multiple metastases (2,10). They generally present in the cortex of the frontal, parietal or temporal lobe, however, they rarely invade the skull and meninges (6). The current study, to the best of our knowledge, is the first reported case of brain metastasis which simultaneously invaded the subgaleal region, the skull, and the dural and cavernous sinuses. In general, such patients can easily be misdiagnosed, so the results of this case report may improve clinical studies of this type.
In December 2010, a 54-year-old female presented at the Tianjin Medical University General Hospital (Tianjin, China) with a progressive headache of the left parietal area of the brain that had persisted for one month. The patient provided written informed consent. The results of the patient examination indicated lethargy, double eyelid edema, a 5×7-cm2 purple swollen area in the left frontal top scalp with tenderness, hypalgesia of the left frontal scalp, chemosis, eye fixation and a positive Babinski sign on the right side. The cerebrospinal fluid pressure was 250 mmH2O, however, no other abnormalities were identified during the physical and laboratory examinations. Coronal contrast-enhanced T1-weighted magnetic resonance imaging (MRI) revealed a soft tissue swelling of the subgaleal tissue of the left frontoparietal area, and a high intensity signal in the dural and cavernous sinuses (Fig. 1). As a result of the observations of the clinical manifestations, the patient was initially diagnosed with an intracranial infection. The patient subsequently underwent a biopsy of the abnormal tissue, which included tissue samples from the skull, dural sinus and subgaleal region. The pathological diagnosis was determined as a metastatic adenocarcinoma (Fig. 2). However, following a series of imaging assessments, the primary tumor was not located. In order to relieve the intracranial hypertension, the patient underwent surgical resection of the majority of the abnormal tissues and received a decompressive craniectomy. The patient’s postoperative course was uneventful and initially the symptoms improved. However, after two weeks, the patient’s neurological condition began to progressively worsen. Axial computed tomography (CT) scan with a bone window demonstrated a bulging growth in the brain tissue, which caused the ventricular system to shift to the left (Fig. 3). Due to the widespread metastasis, the secondary surgical removal had no effect. The patient declined further treatment and succumbed after one month.
According to previous studies, the majority of brain metastases present in the brain parenchyma and rarely invade the skull or the meningeal (11–13). The current case of a patient with a brain metastatic carcinoma invading the subgaleal region, skull, and the dural and cavernous sinuses is considered to be particularly uncommon. In the present case, due to the presence of intracranial hypertension, the sites of high intensity signals in the MRI and the lack of a primary tumor, the patient was misdiagnosed as presenting with an intracranial infection. Therefore, the current case report presents the clinical development of an unusual form of brain metastasis and highlights the necessity for conducting a biopsy as soon as possible in this type of patient.
In conclusion, in the patient described in the present case report, the metastases invaded the subgaleal region, the skull, and the dural and cavernous sinuses simultaneously, which, to the best of our knowledge, has not previously been reported. Although the patient underwent surgery (surgical resection of the majority of the abnormal tissues and a decompressive craniectomy), the patient succumbed after one month, which is consistent with the poor prognosis associated with brain metastases. This patient presented with intracranial hypertension; however, the final diagnosis was determined via pathological examination as a brain metastasis, although the primary tumor was not found during the imaging examinations. Thus, this type of patient may easily be misdiagnosed as exhibiting an intracranial infection, therefore, performance of a biopsy is considered to be necessary in the early stages of the diagnostic procedures. Furthermore, the diagnosis of intracranial malignant metastases must be considered for patients >40-year-old, who present with rapid progression of clinical manifestations, such as a headache and obvious intracranial hypertension, even when no primary tumor is identified. The accurate diagnosis of this type of cancer relies on the results that are obtained via biopsy; however, the prognosis for this type of patient is generally poor.